NCT02197143View on ClinicalTrials.gov

A Comparison of Efficacy of Intravenous Esomeprazole and Ranitidine Treatment of Dyspeptic Pain

PHASE4CompletedINTERVENTIONAL
Enrollment

286

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
Dyspepsia
Interventions
DRUG

esomeprazole

40 mg esomeprazole in 150 ml normal saline given as a slow intravenous infusion over 15 minutes and p.o. 10ml Hydrotalcid

DRUG

Ranitidine

50mg Ranitidine in 150 ml normal saline given as a slow intravenous infusion over 15 minutes and p.o. 10ml Hydrotalcid

DRUG

hydrotalcid

150 ml only normal saline given as a slow intravenous infusion over 15 minutes and p.o. 10ml Hydrotalcid

Trial Locations (1)

20000

Pamukkale Universty, Denizli

All Listed Sponsors
lead

Pamukkale University

OTHER

NCT02197143 - A Comparison of Efficacy of Intravenous Esomeprazole and Ranitidine Treatment of Dyspeptic Pain | Biotech Hunter | Biotech Hunter